These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38899713)

  • 1. Prevention of Cardiovascular Disease in Type 1 Diabetes.
    Wenstedt EFE; Vogt L
    N Engl J Med; 2024 Jun; 390(23):2226. PubMed ID: 38899713
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of Cardiovascular Disease in Type 1 Diabetes.
    Maahs DM; Svensson J
    N Engl J Med; 2024 Jun; 390(23):2226-2227. PubMed ID: 38899714
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing cardiovascular disease in diabetes.
    Harvey JN
    Clin Med (Lond); 2004; 4(4):311-4. PubMed ID: 15372888
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes: Cardiovascular benefits of metformin in T1DM.
    Snell-Bergeon JK
    Nat Rev Endocrinol; 2017 Oct; 13(10):565-566. PubMed ID: 28895950
    [No Abstract]   [Full Text] [Related]  

  • 5. Legacy effect in medicine-the expanding horizon!
    Wander GS; Bansal M
    Indian Heart J; 2018; 70(6):769-771. PubMed ID: 30580842
    [No Abstract]   [Full Text] [Related]  

  • 6. Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes.
    Teleb M; Popp Switzer M; Elhanafi S; Elfar A; San Juan ZT
    Curr Cardiol Rep; 2016 Mar; 18(3):29. PubMed ID: 26886228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A failure to communicate.
    Curry A
    Diabetes Forecast; 2014 Jan; 67(1):92-3. PubMed ID: 25868303
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
    Laakso M
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):682-3. PubMed ID: 18797431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 receptor agonists for improving cardiorenal outcomes in type 1 diabetes mellitus?
    Popovic DS; Stoian AP; Papanas N
    Endocrine; 2023 Apr; 80(1):232-233. PubMed ID: 36607508
    [No Abstract]   [Full Text] [Related]  

  • 10. Is glucose control important for prevention of cardiovascular disease in diabetes?
    Mannucci E; Dicembrini I; Lauria A; Pozzilli P
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S259-63. PubMed ID: 23882055
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular Safety of Current and Emerging Glucose-Lowering Therapies.
    Fitchett D
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S176-82. PubMed ID: 26654861
    [No Abstract]   [Full Text] [Related]  

  • 12. Intensive glycemic control and cardiovascular disease: an update.
    Brown A; Reynolds LR; Bruemmer D
    Nat Rev Cardiol; 2010 Jul; 7(7):369-75. PubMed ID: 20404853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
    Leesar MA
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of diabetes mellitus type 1].
    Scherbaum WA; Hauner H
    Dtsch Med Wochenschr; 2005 Jan; 130(4):141-2. PubMed ID: 15662579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive diabetes treatment and cardiovascular disease.
    Weissman AJ
    N Engl J Med; 2006 Apr; 354(16):1751-2; author reply 1751-2. PubMed ID: 16625015
    [No Abstract]   [Full Text] [Related]  

  • 16. Emerging Targets for Cardiovascular Disease Prevention in Diabetes.
    Stitziel NO; Kanter JE; Bornfeldt KE
    Trends Mol Med; 2020 Aug; 26(8):744-757. PubMed ID: 32423639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs That Improve Cardiovascular Prognosis in Diabetes and Are Not Yet Used by Cardiologists.
    Castro A; Marzal D
    Rev Esp Cardiol (Engl Ed); 2018 Dec; 71(12):999-1000. PubMed ID: 30219492
    [No Abstract]   [Full Text] [Related]  

  • 18. [New drugs for type 2 diabetes: expanding cardiovascular protection beyond type 2 diabetes?].
    Mannucci E
    G Ital Cardiol (Rome); 2012 Dec; 13(12 Suppl 1):3S. PubMed ID: 23258122
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?].
    Laakso M
    Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term continuous subcutaneous insulin infusion (CSII) and cardiovascular complications: Higher fractional use is not biased by risk factors.
    Tubili C; Nardone MR; Pollakova D; Di Folco U
    Diabetes Metab Res Rev; 2020 Jul; 36(5):e3306. PubMed ID: 32129928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.